Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease

N/ACompletedNCT03331926

Jeppe Lange199 enrolled

Overview

To evaluate the effect of collagenase clostridium histolyticum treatment at the Department of Orthopaedic surgery at Horsens Regional Hospital after minimum one-year follow-up (FU).

Study Type

OBSERVATIONAL

Enrollment

199

Conditions

Dupuytren Contracture

Interventions

XiapexDRUG

Follow-up of effect of treatment

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * dupuytrens disease * xiapex treatment Exclusion Criteria: \- demens/other psychiatric diseases

Outcomes

Primary Outcomes

Change in extension deficit from baseline to FU in MCP and PIP joints after treatment

Time frame: Minimum one year after treatment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.